Detalles de la búsqueda
1.
Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples.
J Clin Microbiol
; 59(7): e0083721, 2021 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903166
2.
Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort.
BMC Infect Dis
; 20(1): 172, 2020 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32087680
3.
Association between serotonin transporter gene polymorphisms and increased suicidal risk among HIV positive patients in Uganda.
BMC Genet
; 18(1): 71, 2017 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28743254
4.
Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners.
J Virol
; 87(16): 9053-63, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23760253
5.
The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies.
Front Immunol
; 15: 1325387, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38469296
6.
Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations.
Front Immunol
; 15: 1348905, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357547
7.
The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort.
Front Immunol
; 15: 1384668, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38779677
8.
An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2.
Bio Protoc
; 13(24): e4905, 2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38156036
9.
Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda.
Front Immunol
; 14: 1113194, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999017
10.
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.
Hum Vaccin Immunother
; 19(2): 2240690, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37553178
11.
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy.
Front Immunol
; 14: 1183983, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37205095
12.
Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals.
Front Immunol
; 14: 1255676, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38098482
13.
Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens.
Front Immunol
; 14: 1148877, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37153598
14.
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months.
Front Immunol
; 14: 1152522, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37006272
15.
Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection.
Int J Infect Dis
; 136: 49-56, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683720
16.
Bacterial microbiome and host inflammatory gene expression in foreskin tissue.
Heliyon
; 9(11): e22145, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38053902
17.
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin.
AIDS
; 37(11): 1651-1659, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37289572
18.
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.
EBioMedicine
; 93: 104648, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37327677
19.
Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.
PLoS One
; 17(11): e0275927, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327320
20.
Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa.
Front Immunol
; 13: 1009978, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479111